Financials
- Market Capitalization 2.94 M
- Employee 2
- Founded 2013
- CEO N/A
- Website www.matinasbiopharma.com
- Headquarter Delaware, United States
- FIGI BBG005WX2XG8
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 5020 | ARTL Artelo Biosciences, Inc. - Common Stock | 0.66 USD | 0.00% | -2.94% | -13.16% | -45.00% | 3.03 M USD | ||
| 5022 | GNPX Genprex, Inc. - Common Stock | 3.67 USD | +1.66% | -8.71% | -48.74% | +96.26% | 3.01 M USD | ||
| 5028 | BCAB BioAtla, Inc. - Common Stock | 1.74 USD | -44.59% | -46.79% | -48.06% | +270.21% | 2.90 M USD | ||
| 5046 | ONCO Onconetix, Inc. - Common Stock | 0.61 USD | -3.17% | -6.15% | -12.86% | -19.74% | 2.41 M USD |
Frequently asked questions about Matinas BioPharma Holdings, Inc.
What is the Matinas BioPharma Holdings, Inc. stock price today?
The current price of Matinas BioPharma Holdings, Inc. (MTNB) is 0.20. Over the past 24 hours, the stock has changed by 0.00%. Follow the MTNB chart for real-time price dynamics.
What is the stock ticker of Matinas BioPharma Holdings, Inc.?
Matinas BioPharma Holdings, Inc. trades under the ticker MTNB. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Matinas BioPharma Holdings, Inc. stock going up?
MTNB has changed by +5.26% over the last week, -33.33% over the last month, and -67.75% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Matinas BioPharma Holdings, Inc.?
Matinas BioPharma Holdings, Inc. currently has a market capitalization of 2.94 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Matinas BioPharma Holdings, Inc. earnings last quarter?
Last quarter, Matinas BioPharma Holdings, Inc. reported earnings of -0.21 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Matinas BioPharma Holdings, Inc. revenue for the last quarter?
Matinas BioPharma Holdings, Inc. reported quarterly revenue of -138 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Matinas BioPharma Holdings, Inc. net income for the last quarter?
Matinas BioPharma Holdings, Inc. reported net income of -1.33 M for the last quarter. The previous quarter showed -1.92 M, which means net income changed by +30.97%.
How many employees does Matinas BioPharma Holdings, Inc. have?
As of the latest available data, Matinas BioPharma Holdings, Inc. has 2 employees. Workforce size can provide additional context about the company's scale and operations.
What is Matinas BioPharma Holdings, Inc. EBITDA?
Matinas BioPharma Holdings, Inc. EBITDA is -1.69 M, and its EBITDA margin is 1 226.09%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Matinas BioPharma Holdings, Inc. stock?
You can buy Matinas BioPharma Holdings, Inc. (MTNB) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Matinas BioPharma Holdings, Inc. stock?
Investing in Matinas BioPharma Holdings, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the MTNB chart and related analysis on metatrader.com as part of your research.